Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
STMicroelectronics
STM
$46.7B
| $485K | ﹤0.01% |
+11,215
| New | +$506K |
|
2877
Choiceone Financial
COFS
$509M
| $484K | ﹤0.01% |
17,700
+1,000
| +6% | +$26.9K |
|
2878
RAVE Restaurant Group
RAVE
$44.8M
| $484K | ﹤0.01% |
221,022
+16,900
| +8% | +$33K |
|
2879
Equillium
EQ
$139M
| $483K | ﹤0.01% |
209,200
-138,300
| -40% | -$240K |
|
2880
Nabors Industries
NBR
$1.27B
| $482K | ﹤0.01% |
5,600
-45,800
| -89% | -$3.75M |
|
2881
Lakeland Financial Corp
LKFN
$1.56B
| $481K | ﹤0.01% |
+7,251
| New | +$469K |
|
|
SGMA
2882
DELISTED
Sigmatron International
SGMA
| $479K | ﹤0.01% |
132,087
+2,000
| +2% | +$6.72K |
|
2883
Innoviz Technologies
INVZ
$95M
| $478K | ﹤0.01% |
+353,754
| New | +$594K |
|
2884
Ovid Therapeutics
OVID
$414M
| $478K | ﹤0.01% |
156,800
+105,600
| +206% | +$353K |
|
2885
Oportun Financial
OPRT
$255M
| $475K | ﹤0.01% |
195,585
+21,085
| +12% | +$76.2K |
|
2886
NCR Atleos
NATL
$3.47B
| $474K | ﹤0.01% |
+24,000
| New | +$513K |
|
|
CTHR
2887
DELISTED
Charles & Colvard Ltd
CTHR
| $473K | ﹤0.01% |
138,637
-3,720
| -3% | -$14.2K |
|
2888
argenx
ARGX
$53.4B
| $472K | ﹤0.01% |
+1,200
| New | +$465K |
|
|
IRS
2889
IRSA Inversiones y Representaciones
IRS
$1.29B
| $472K | ﹤0.01% |
52,242
+3,810
| +8% | +$30.5K |
|
2890
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
| $472K | ﹤0.01% |
+2,000
| New | +$448K |
|
2891
Solitario Resources
XPL
$68.3M
| $469K | ﹤0.01% |
782,018
+51,846
| +7% | +$28K |
|
2892
Better Online Solutions
BOSC
$31.7M
| $467K | ﹤0.01% |
153,116
-2,195
| -1% | -$6.01K |
|
|
FINV
2893
FinVolution Group
FINV
$1.15B
| $464K | ﹤0.01% |
92,100
-1,800
| -2% | -$8.87K |
|
|
IGMS
2894
DELISTED
IGM Biosciences
IGMS
| $464K | ﹤0.01% |
48,100
+11,500
| +31% | +$133K |
|
2895
Hamilton Beach Brands
HBB
$311M
| $463K | ﹤0.01% |
19,000
-8,692
| -31% | -$169K |
|
|
TSRI
2896
DELISTED
TSR Inc. New
TSRI
| $463K | ﹤0.01% |
58,650
-1,726
| -3% | -$14.6K |
|
|
CGC
2897
Canopy Growth
CGC
$387M
| $461K | ﹤0.01% |
53,469
-25,839
| -33% | -$112K |
|
|
VTRU
2898
DELISTED
Vitru Limited Common Shares
VTRU
| $461K | ﹤0.01% |
30,610
-400
| -1% | -$5.71K |
|
2899
Cardiff Oncology
CRDF
$66.5M
| $460K | ﹤0.01% |
86,100
-30,300
| -26% | -$80.5K |
|
2900
Minerva Neurosciences
NERV
$185M
| $459K | ﹤0.01% |
177,765
+70,565
| +66% | +$433K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.